Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.35
Delayed Data
As of Aug 28
 +0.12 / +9.76%
Today’s Change
0.92
Today|||52-Week Range
2.75
+35.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues1.9M1.9M475.0K462.0K
 
 
 
 
 
Cost of Goods Sold423.0K290.0K159.0K434.0K
 
 
 
 
 
Depreciation And Amortization62.0K68.0K74.0K75.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M1.5M242.0K-47.0K
 
 
 
 
 
General Expenses4.6M18.6M6.4M5.8M
 
 
 
 
 
Research And Development1.9M15.9M3.3M3.1M
 
 
 
 
 
Total Operating Expenses5.1M19.0M6.6M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-17.1M-6.1M-5.8M
 
 
 
 
 
Extraordinary Credit95.0K--0.00747.0K
 
 
 
Extraordinary Charge---82.0K-136.0K0.00
 
 
 
Interest Expense On Debt44.0K119.0K146.0K157.0K
 
 
 
 
 
Other Expenses-1.0K-8.0K-8.0K-12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.1M-17.3M-6.4M-5.2M
 
 
 
 
 
Discontinued Operations19.0K0.000.000.00
 
 
Net Income-3.1M-17.3M-6.4M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.1M43.2M47.6M50.4M
 
 
 
 
 
Shares To Calculate EPS Diluted39.1M43.2M47.6M50.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.40-$0.13-$0.10
 
 
 
 
 
EPS Diluted-$0.08-$0.40-$0.13-$0.10